Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2026
|
| Schlagworte: | |
| Online-Zugang: | https://onlinelibrary.wiley.com/doi/10.1002/ptr.70331 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867016697954697216 |
|---|---|
| author | Han‐Lin Lu Der‐Yen Lee Yi‐Wen Huang Chung‐Yu Chen Tung‐Ti Chang Wei‐Chao Chang Mei‐Fen Chen Jia‐Hau Yen Sheng‐Teng Huang |
| author_facet | Han‐Lin Lu Der‐Yen Lee Yi‐Wen Huang Chung‐Yu Chen Tung‐Ti Chang Wei‐Chao Chang Mei‐Fen Chen Jia‐Hau Yen Sheng‐Teng Huang Han‐Lin Lu Der‐Yen Lee Yi‐Wen Huang Chung‐Yu Chen Tung‐Ti Chang Wei‐Chao Chang Mei‐Fen Chen Jia‐Hau Yen Sheng‐Teng Huang |
| collection | Wiley Open Access |
| contents | Pueraria montana var. lobata Root Extract Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Increasing Mitochondrial β‐Oxidation and Mitochondrial‐Peroxisome Contact Han‐Lin Lu Der‐Yen Lee Yi‐Wen Huang Chung‐Yu Chen Tung‐Ti Chang Wei‐Chao Chang Mei‐Fen Chen Jia‐Hau Yen Sheng‐Teng Huang Phytotherapy Research ABSTRACT Pueraria montana var. lobata (Willd.) is a well‐known herbal medicine, also referred to as “kudzu.” It is used in traditional Chinese medicine to treat various medical conditions, including diabetes, cardiovascular diseases, diarrhea, and hypertension. Additionally, Pueraria montana var. lobata is considered a functional food widely recognized to enhance the immune system and treat hyperlipidemia. We aim to evaluate the effects of Pueraria montana var. lobata extract (PLE) on the development of inflammation and the progression to metabolic dysfunction‐associated steatotic liver disease (MASLD) by investigating the effects and underlying mechanisms both in vivo and in vitro under metabolic stress. To address whether PLE can reverse established MASLD/fibrosis, we performed a robust hepatosteatosis study in mice fed with a Western diet (WD) and PLE. AML12 and HepG2 cells were exposed to OA and/or PA at different concentrations and combinations. Intracellular lipids and cell viability were detected with Oil Red O staining and CCK8 assay, respectively. Confocal microscopy was employed to analyze mitochondrial functions and their relative positions to peroxisomes. PLE treatment significantly reduced lipid accumulation, inflammatory response, liver injury, and fibrosis in mice fed a high‐fat diet. RNA‐sequencing indicated that the key mechanism underlying the anti‐MASLD effects of PLE was higher peroxisome activity and the subsequent increase in β‐oxidation flux. PLE concurrently decreased cholesterol‐raising saturated fatty acids and increased polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) in AML12 mouse liver cells treated with OA. Confocal images revealed the intracellular transport route between mitochondria and peroxisomes after PLE treatment. There are currently no FDA‐approved therapies for MASLD. Our study demonstrates that PLE prevents metabolic stress‐induced MASLD progression through direct activation of CPT1A signaling, suggesting that PLE may be considered a therapeutic candidate for the treatment of MASLD. 10.1002/ptr.70331 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/ptr.70331 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_ptr_70331 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Pueraria montana var. lobata Root Extract Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Increasing Mitochondrial β‐Oxidation and Mitochondrial‐Peroxisome Contact Han‐Lin Lu Der‐Yen Lee Yi‐Wen Huang Chung‐Yu Chen Tung‐Ti Chang Wei‐Chao Chang Mei‐Fen Chen Jia‐Hau Yen Sheng‐Teng Huang Phytotherapy Research Pueraria montana var. lobata Root Extract Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Increasing Mitochondrial β‐Oxidation and Mitochondrial‐Peroxisome Contact Han‐Lin Lu Der‐Yen Lee Yi‐Wen Huang Chung‐Yu Chen Tung‐Ti Chang Wei‐Chao Chang Mei‐Fen Chen Jia‐Hau Yen Sheng‐Teng Huang Phytotherapy Research ABSTRACT Pueraria montana var. lobata (Willd.) is a well‐known herbal medicine, also referred to as “kudzu.” It is used in traditional Chinese medicine to treat various medical conditions, including diabetes, cardiovascular diseases, diarrhea, and hypertension. Additionally, Pueraria montana var. lobata is considered a functional food widely recognized to enhance the immune system and treat hyperlipidemia. We aim to evaluate the effects of Pueraria montana var. lobata extract (PLE) on the development of inflammation and the progression to metabolic dysfunction‐associated steatotic liver disease (MASLD) by investigating the effects and underlying mechanisms both in vivo and in vitro under metabolic stress. To address whether PLE can reverse established MASLD/fibrosis, we performed a robust hepatosteatosis study in mice fed with a Western diet (WD) and PLE. AML12 and HepG2 cells were exposed to OA and/or PA at different concentrations and combinations. Intracellular lipids and cell viability were detected with Oil Red O staining and CCK8 assay, respectively. Confocal microscopy was employed to analyze mitochondrial functions and their relative positions to peroxisomes. PLE treatment significantly reduced lipid accumulation, inflammatory response, liver injury, and fibrosis in mice fed a high‐fat diet. RNA‐sequencing indicated that the key mechanism underlying the anti‐MASLD effects of PLE was higher peroxisome activity and the subsequent increase in β‐oxidation flux. PLE concurrently decreased cholesterol‐raising saturated fatty acids and increased polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) in AML12 mouse liver cells treated with OA. Confocal images revealed the intracellular transport route between mitochondria and peroxisomes after PLE treatment. There are currently no FDA‐approved therapies for MASLD. Our study demonstrates that PLE prevents metabolic stress‐induced MASLD progression through direct activation of CPT1A signaling, suggesting that PLE may be considered a therapeutic candidate for the treatment of MASLD. 10.1002/ptr.70331 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Pueraria montana var. lobata Root Extract Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Increasing Mitochondrial β‐Oxidation and Mitochondrial‐Peroxisome Contact |
| topic | Phytotherapy Research |
| url | https://onlinelibrary.wiley.com/doi/10.1002/ptr.70331 |